Detection of Tumor Recurrence via Circulating Tumor DNA Profiling in Patients with Localized Lung Cancer: Clinical Considerations and Challenges

SIMPLE SUMMARY: Circulating tumor DNA is a novel biomarker with emerging uses in the clinical care of patients with cancer, including non-small-cell lung cancer. Already approved for use in various clinical settings in patients with metastatic non-small-cell lung cancer, recent research has focused...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulrich, Bryan, Pradines, Anne, Mazières, Julien, Guibert, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345193/
https://www.ncbi.nlm.nih.gov/pubmed/34359659
http://dx.doi.org/10.3390/cancers13153759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345193/
https://www.ncbi.nlm.nih.gov/pubmed/34359659
http://dx.doi.org/10.3390/cancers13153759

Ejemplares similares